Columbia Sportswear Company
$3.10B- Market cap
- $2.96B
- Debt
- +$938.28M
- Cash
- −$790.79M
Capital structure 76% equity / 24% debt · EV / Revenue 0.91x · EV / EBITDA 10.83x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: COLM stock price at discount vs SUPN $57.74 current versus $233.67 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUPN's multiple
Implied fair value · at COLM's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: COLM FY 2025 (ended Dec 31, 2025) · SUPN FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 76% equity / 24% debt · EV / Revenue 0.91x · EV / EBITDA 10.83x
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.55x
COLM carries the larger enterprise value at $3.10B against $2.45B; COLM trades on the lower EV / Revenue multiple (0.91x vs 3.40x); COLM on the lower EV / EBITDA (10.83x vs 50.55x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
COLUMBIA SPORTSWEAR COMPANY · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SUPERNUS PHARMACEUTICALS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.55x
0.04x
Net debt / EBITDA
Leverage against operating earnings
0.51x
-1.75x
Cash and equivalents
Liquid reserves on the balance sheet
$790.79M
$128.45M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
V F CORP
COLM vs VFC
lululemon athletica inc.
COLM vs LULU
Under Armour, Inc.
COLM vs UAA
PVH CORP. /DE/
COLM vs PVH
NIKE, Inc.
COLM vs NKE
Jazz Pharmaceuticals plc
COLM vs JAZZ
INCYTE CORP
COLM vs INCY
ANI PHARMACEUTICALS INC
COLM vs ANIP
Vanda Pharmaceuticals Inc.
COLM vs VNDA
Harmony Biosciences Holdings, Inc.
COLM vs HRMY
$938.28M
$43.80M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.